Elevated serum level of sialylated glycoprotein KL-6 predicts a poor prognosis in patients with non-small cell lung cancer treated with gefitinib

Authors:
  • STShinichi Toyooka
    Shinichi Toyooka
  • KHKatsuyuki Hotta
    Katsuyuki Hotta
  • MTMasahiro Tabata
    Masahiro Tabata
  • NTNagio Takigawa
    Nagio Takigawa
  • JSJunichi Soh
    Junichi Soh
  • YTYasushi Tanimoto
    Yasushi Tanimoto
  • KKKatsuya Kato
    Katsuya Kato
  • HDHiroshi Date
    Hiroshi Date
  • MTMitsune Tanimoto
    Mitsune Tanimoto

Abstract
No abstract available

This publication has 23 references indexed in Scilit: